- Home
- MREO vs EUDA Comparison
MREO vs EUDA Comparison
Compare MREO & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | EUDA |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United Kingdom | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 68.7M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | MREO | EUDA |
|---|---|---|
| Price | $0.35 | $0.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $3.13 | $2.75 |
| AVG Volume (30 Days) | ★ 1.5M | 150.8K |
| Earning Date | 03-19-2026 | 12-19-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | $137.25 |
| Revenue Next Year | $6,363.05 | $361.43 |
| P/E Ratio | ★ N/A | $123.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.36 |
| 52 Week High | $2.94 | $4.30 |
Technical Indicators
Market Signals| Indicator | MREO | EUDA |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 23.44 |
| Support Level | $0.20 | N/A |
| Resistance Level | $0.42 | $1.00 |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 22.62 | 8.60 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.